Patent details

Basic Information

Publication number:

EP2976064

PCT Application Number:

IB2014059965

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147172027

PCT Publication Number:

WO2014147567

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE L'ÉVÉROLIMUS

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT EVEROLIMUS

SPC Number:

Dates

Filing date:

19/03/2014

Grant date:

19/04/2017

EP Publication Date:

27/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/04/2017

EP B1 Publication Date:

19/04/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/03/2018

Expiration date:

19/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/04/2017

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

DIEDERICH, Anke

Address:

Switzerland (CH)

2

Name:

GRANER, Oliver

Address:

Switzerland (CH)

3

Name:

KUNZLER, Hans-Ulrich

Address:

Switzerland (CH)

Priority

Priority Number:

201361803300 P

Priority Date:

19/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/16; A61K 9/20; A61K 9/28; A61K 9/50; A61K 31/436;

Publication

European Patent Bulletin

Issue number:

201716

Publication date:

19/04/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1